Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000385335 | SCV000343504 | uncertain significance | not provided | 2018-02-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001514036 | SCV001721781 | benign | Peroxisome biogenesis disorder 7A (Zellweger); Peroxisome biogenesis disorder 7B | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000385335 | SCV002541711 | uncertain significance | not provided | 2021-06-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003977805 | SCV004798422 | likely benign | PEX26-related disorder | 2023-03-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |